Five-month booster possible ‘in certain circumstances’: ATAGI No changes have been prompted by the Omicron variant, but the advisory group says a shortened minimum gap can be followed if specific conditions are met.
Immunocompromised require third COVID vaccine dose: ATAGI The additional dose is considered part of the primary regimen and is intended to generate an immune response equivalent to the general population.
ATAGI says third vaccine dose ‘likely’ for certain cohorts The advisory body has said ‘severely immunocompromised’ people will be among those expected to require an additional dose.
Government clarifies GPs’ position as states expand Pfizer eligibility The Department of Health has confirmed GPs can mirror states on Pfizer eligibility for over-60s.
General practice to follow state Pfizer criteria GPs in South Australia and the Northern Territory will soon begin administering the Pfizer vaccine to over-60s in line with state-run mass vaccination hubs, and other states could soon follow.
Reports of non-GP specialists advising patients to wait for Pfizer GPs say they feel like gatekeepers of Pfizer, with some patients over 60 presenting with exemption letters despite having no contraindications to AstraZeneca.
No Moderna access for general practice in 2021 Ten million doses of the mRNA vaccine will be prioritised for pharmacies and workplace vaccination programs, the Department of Health has said.
ATAGI gives green light to Pfizer for at-risk children as young as 12 The RACGP has backed the decision, which marks the first time Australia’s vaccine rollout has opened to children under 16.
ATAGI updates AstraZeneca advice as NSW cases increase All adults in Greater Sydney should ‘strongly consider’ the vaccine amid the worsening COVID outbreak, the advisory group said.
RACGP calls for COVID vaccine consistency The college wants state and federal governments to clarify eligibility criteria and promote consistency between jurisdictions.